Incyte (INCY) Selling, General & Administrative (2010 - 2026)
Incyte (INCY) posted Selling, General & Administrative of $351.74 million for Q2 2026, up 6.3% from $331.02 million a year earlier and up 7.2% from the prior quarter.
Powered by 
Analysis
Incyte (INCY) Selling, General & Administrative (2010 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Selling, General & Administrative at Incyte was $1.4 billion, up 8.3% year-over-year; for FY2025, it was $1.38 billion, up 10.8% from FY2024.
- Annual Selling, General & Administrative has increased for 16 consecutive years, with a five-year compound annual growth rate of 21.6% (FY2020 to FY2025).
- In prior years, Incyte's Selling, General & Administrative was $1.24 billion in FY2024 (+7.5%), $1.16 billion in FY2023 (+15.3%), $1 billion in FY2022 (+35.5%) and $739.56 million in FY2021 (+43.1%).
- Quarterly Selling, General & Administrative has run from a low of $190.7 million in Q3 2021 to a high of $390.41 million in Q4 2025 over five years.
- On a year-over-year basis, Selling, General & Administrative has increased in each of the last nine quarters, with growth averaging 9.8% over the last eight quarters.
- The strongest year-over-year quarter for Selling, General & Administrative in the past five years was Q3 2021, with growth of 57.9%; the weakest was Q1 2024, with a decline of 4.9%.
- According to Business Quant data, Selling, General & Administrative for the three prior quarters was $328.09 million (Q1 2026), $390.41 million (Q4 2025) and $329.08 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 3.43 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 6.43 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 3.63 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 2.90 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | -3.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | -5.65 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 1.75 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 1.92 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 3.41 Bn |
| 10 | Incyte | 23.17 Bn | 8.11 Bn | 1.57 Bn | 351.74 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 351.74 Mn |
| Mar 31, 2026 | 328.09 Mn |
| Dec 31, 2025 | 390.41 Mn |
| Sep 30, 2025 | 329.08 Mn |
| Jun 30, 2025 | 331.02 Mn |
| Mar 31, 2025 | 325.69 Mn |
| Dec 31, 2024 | 326.71 Mn |
| Sep 30, 2024 | 309.21 Mn |
| Jun 30, 2024 | 305.98 Mn |
| Mar 31, 2024 | 300.26 Mn |
| Dec 31, 2023 | 288.23 Mn |
| Sep 30, 2023 | 267.89 Mn |
| Jun 30, 2023 | 283.93 Mn |
| Mar 31, 2023 | 315.61 Mn |
| Dec 31, 2022 | 272.82 Mn |
| Sep 30, 2022 | 266.46 Mn |
| Jun 30, 2022 | 253.28 Mn |
| Mar 31, 2022 | 209.58 Mn |
| Dec 31, 2021 | 226.20 Mn |
| Sep 30, 2021 | 190.70 Mn |
API Access
Incyte Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=INCY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "INCY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=INCY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();